This inventor holds 1 USPTO granted patent. Top assignee: Warren-Teed Laboratories, Inc.. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: The Innovative Contributions of David T. Drees
Introduction
David T. Drees is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of medicine, particularly in the treatment of gallstones. His innovative approach combines established medical compounds to enhance patient outcomes.
Latest Patents
David T. Drees holds a patent for a safer method for dissolving gallstones that utilizes hyodeoxycholic acid (HDCA). This method demonstrates that the administration of HDCA alongside chenodeoxycholic acid (CDCA) results in a reduction of serum glutamic-oxaloacetic transaminase, serum glutamic-pyruvate transaminase, and alkaline phosphatase levels in the blood compared to the administration of CDCA alone. This patent highlights his commitment to improving medical treatments and patient safety.
Career Highlights
David T. Drees is associated with Warren-Teed Laboratories, Inc., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a valuable asset in his organization.
Collaborations
David collaborates with Anthony R. Imondi, leveraging their combined expertise to advance their projects and contribute to the field of medicine.
Conclusion
David T. Drees exemplifies the spirit of innovation through his patent and work at Warren-Teed Laboratories, Inc. His contributions to the medical field, particularly in gallstone treatment, reflect his commitment to enhancing patient care and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile